glutathione rapta c State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases Duration:30 day supply (2 packages) Vitamin B12 Injection Service requiredPrescription

glutathione rapta c State of Metal-Based Drugs for the Efficient Therapy of Lung Cancers and Lung Metastases Duration:30 day supply (2 packages) Vitamin B12 Injection Service requiredPrescription

Vitamin B12 Injection Service - Pontprennau Pharmacy

Product Specifications Specification Detail Product typeMEM Product categoryCell culture media FormatLiquid SterileYes Size500 ml L-GlutamineWith L-glutamine (2 mM) GlucoseWith glucose (1.0 g/L) Sodium bicarbonateWith NaHCO3 (2.2 g/L) HEPESWithout HEPES Sodium pyruvateWithout sodium pyruvate Phenol redWith phenol red Salt solutionEarle’s Balanced Salt Solution (EBSS) pH7.0 – 7.6 Endotoxin contentNot specified Storage+2 °C to +8 °C Formulation (Composition per Liter) Component Concentration (mg/L) Inorganic Salts Calcium chloride · 2H2O265.00 Magnesium sulfate97.72 Potassium chloride400.00 Sodium chloride6,800.00 Sodium dihydrogen phosphate, anhydrous122.00 Sodium bicarbonate (NaHCO3)2,200.00 Amino Acids L-Arginine · HCl126.00 L-Cystine · 2HCl31.30 L-Glutamine292.00 L-Histidine · HCl · H2O42.00 L-Isoleucine52.00 L-Leucine52.00 L-Lysine · HCl72.50 L-Methionine15.00 L-Phenylalanine32.00 L-Threonine48.00 L-Tryptophan10.00 L-Tyrosine · 2Na · 2H2O51.90 L-Valine46.00 Vitamins D-Calcium pantothenate1.00 Choline chloride1.00 Folic acid1.00 myo-Inositol2.00 Nicotinamide1.00 Pyridoxal · HCl1.00 Riboflavin0.10 Thiamine · HCl1.00 Other Components D(+)-Glucose1,000.00 Phenol red10.00€25.00*Accutase Cell Detachment Solution - 100 mlVariants: 100 mlAccutase Cell Detachment Solution with EDTA and Phenol Red – 100 ml Accutase is a ready-to-use, sterile-filtered cell detachment solution designed as a gentle alternative to trypsin/EDTA for dissociating adherent mammalian cells from standard tissue culture plasticware and adhesion-coated surfaces

requiredPrescription

Duration:30 day supply (2 packages)

We propose that trimetazidine is a promising drug that can be repurposed to target mitochondrial dysfunction, inflammation and oxidative stress to treat bipolar depression